Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine Excretion Into Breast Milk in Healthy Lactating Female Subjects
NCT07378865Phase 1Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Feb 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of suzetrigine in pain, sponsored by Vertex Pharmaceuticals. Primary endpoints: Total Amount of SUZ in Breast Milk of Lactating Female Participants and Total Amount of SUZ Metabolite in Breast Milk of Lactating Female Participants. Started Feb 2026; status: completed.
02
Drugs
suzetrigine
03
Conditions
pain
Beyond the preview
Go deeper on NCT07378865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07378865.